Our study indicates that the TMB, immune score, and immune cell abundance in TP53 mutant HCC are reduced, and that TP53 mutations may also cause tumorigenesis and a poor prognosis through tumor immunosuppressive mechanisms. The gene discussed is TP53; the disease is neoplasm.